Literature DB >> 20676713

Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004.

L Lambertsen1, K Ekelund, I C Skovsted, A Liboriussen, H-C Slotved.   

Abstract

The aim of this study was to characterise the group B streptococci (GBS) isolates causing severe invasive infections in patients >15 years of age in Denmark from 1999 to 2004. A total of 411 invasive GBS isolates were phenotypically characterised by the capsular polysaccharide (CPS) serotype and protein Calpha, Cbeta and R4. The incidence of invasive GBS disease ranged from 2.2 to 3.2 per 100,000 adults in the study period, being highest among adults over 65 years of age. Diabetes was observed in 15% of the cases, 12% had alcohol abuse and 7% had cancer. Of all isolates, 77% were CPS serotypes Ia, Ib, III or V. The surface proteins Calpha or R4 were detected as the only protein in 57% of the GBS isolates. Cbeta was detected in 12% of the isolates, but always in combination with either Calpha or both Calpha and R4. The incidence of invasive GBS infections continued to increase in Denmark from 1999 to 2004. In that period, the overall case fatality was 14%. The most prevalent CPS serotypes were serotypes III, Ia, V and Ib. The most prevalent surface protein was R4 when testing for R4, Calpha and Cbeta. There was no clear relation between the GBS phenotype and infections with fatal outcome.

Entities:  

Mesh:

Year:  2010        PMID: 20676713     DOI: 10.1007/s10096-010-0941-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method.

Authors:  H-C Slotved; S Sauer; H B Konradsen
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Identification of a universal Group B streptococcus vaccine by multiple genome screen.

Authors:  Domenico Maione; Immaculada Margarit; Cira D Rinaudo; Vega Masignani; Marirosa Mora; Maria Scarselli; Hervé Tettelin; Cecilia Brettoni; Emilia T Iacobini; Roberto Rosini; Nunzio D'Agostino; Lisa Miorin; Scilla Buccato; Massimo Mariani; Giuliano Galli; Renzo Nogarotto; Vincenzo Nardi-Dei; Vincenzo Nardi Dei; Filipo Vegni; Claire Fraser; Giuseppe Mancuso; Giuseppe Teti; Lawrence C Madoff; Lawrence C Paoletti; Rino Rappuoli; Dennis L Kasper; John L Telford; Guido Grandi
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

3.  Invasive group B streptococcal disease in Maryland nursing home residents.

Authors:  K J Henning; E L Hall; D M Dwyer; L Billmann; A Schuchat; J A Johnson; L H Harrison
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

4.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

Review 5.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women.

Authors:  C S Lachenauer; D L Kasper; J Shimada; Y Ichiman; H Ohtsuka; M Kaku; L C Paoletti; P Ferrieri; L C Madoff
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

Review 7.  Group B streptococcal infections in elderly adults.

Authors:  Morven S Edwards; Carol J Baker
Journal:  Clin Infect Dis       Date:  2005-08-16       Impact factor: 9.079

8.  Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001.

Authors:  E Persson; S Berg; B Trollfors; P Larsson; E Ek; E Backhaus; B E B Claesson; L Jonsson; G Rådberg; T Ripa; S Johansson
Journal:  Clin Microbiol Infect       Date:  2004-09       Impact factor: 8.067

9.  Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups.

Authors:  Z Zhao; F Kong; X Zeng; H F Gidding; J Morgan; G L Gilbert
Journal:  Clin Microbiol Infect       Date:  2008-01-07       Impact factor: 8.067

10.  Serotype IX, a Proposed New Streptococcus agalactiae Serotype.

Authors:  Hans-Christian Slotved; Fanrong Kong; Lotte Lambertsen; Susanne Sauer; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

View more
  21 in total

1.  Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.

Authors:  Constantin Hays; Mathilde Louis; Céline Plainvert; Nicolas Dmytruk; Gérald Touak; Patrick Trieu-Cuot; Claire Poyart; Asmaa Tazi
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

2.  Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

3.  Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains.

Authors:  Sarah Teatero; Taryn B T Athey; Paul Van Caeseele; Greg Horsman; David C Alexander; Roberto G Melano; Aimin Li; Anthony R Flores; Samuel A Shelburne; Allison McGeer; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

4.  Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.

Authors:  Sarah Teatero; Allison McGeer; Donald E Low; Aimin Li; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

Review 5.  Group B Streptococcus vaccine: state of the art.

Authors:  Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal:  Ther Adv Vaccines       Date:  2015-05

Review 6.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

7.  Human Streptococcus agalactiae strains in aquatic mammals and fish.

Authors:  Christian M J Delannoy; Margaret Crumlish; Michael C Fontaine; Jolinda Pollock; Geoff Foster; Mark P Dagleish; James F Turnbull; Ruth N Zadoks
Journal:  BMC Microbiol       Date:  2013-02-18       Impact factor: 3.605

8.  Advantages and limitations of ribosomal RNA PCR and DNA sequencing for identification of bacteria in cardiac valves of danish patients.

Authors:  Michael Kemp; Jette Bangsborg; Anne Kjerulf; Thomas Andersen Schmidt; John Christensen; Akhmadjon 6 Irmukhamedov; Niels Eske Bruun; Rimtas Dargis; Keld Andresen; Jens Jørgen Christensen
Journal:  Open Microbiol J       Date:  2013-12-27

9.  Evidence of Common Isolates of Streptococcus agalactiae in Bovines and Humans in Emilia Romagna Region (Northern Italy).

Authors:  Elena Carra; Simone Russo; Alessia Micheli; Chiara Garbarino; Matteo Ricchi; Federica Bergamini; Patrizia Bassi; Alice Prosperi; Silvia Piva; Monica Cricca; Roberta Schiavo; Giuseppe Merialdi; Andrea Serraino; Norma Arrigoni
Journal:  Front Microbiol       Date:  2021-06-11       Impact factor: 5.640

10.  What are the most important infectious diseases among those ≥65 years: a comprehensive analysis on notifiable diseases, Norway, 1993-2011.

Authors:  Anneke Steens; Hanne-Merete Eriksen; Hans Blystad
Journal:  BMC Infect Dis       Date:  2014-02-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.